Your session is about to expire
← Back to Search
Niacin for Obesity
Study Summary
This trial will study the effects of muscle insulin resistance on upper body obesity and Type 2 diabetes, and whether lowering free fatty acids (FFA) with an intravenous infusion of niacin affects muscle glucose uptake.
- Obesity
- Type 2 Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 4 trial • 30 Patients • NCT00203476Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
For what medical treatments is Niacin commonly prescribed?
"Niacin is frequently utilized to reduce cardiovascular risk, as well as managing dyslipidemias, lipidemia and even the potential of pancreatitis."
Are there vacancies in this trial for participants?
"Judging from clinicaltrials.gov, this research is currently seeking participants. The trial was initially posted on November 1st 2018 and the data has been recently revised as of April 13th 2022."
Who has the prerogative to participate in this scientific experiment?
"In order to meet the eligibility requirements of this trial, applicants must have type 2 diabetes mellitus and be between 18-55 years old. This clinical research is seeking 20 volunteers in total."
What is the maximum capacity for participants in this clinical trial?
"Affirmative. Clinicaltrials.gov's records demonstrate that this clinical study, initially unveiled on November 1st 2018, is currently enrolling patients. The endeavour needs to acquire 20 participants from a single location."
Does the research include individuals who are more than twenty years of age?
"To be eligible for participation, participants need to have attained the age of majority and must not exceed 55 years."
Share this study with friends
Copy Link
Messenger